miR-376c-3p modulates the properties of breast cancer stem cells by targeting RAB2A.
In conclusion, the results indicated that miR-376c-3p targeted RAB2A to regulate BCSC fate and properties; therefore, miR-376c-3p may serve as a potential therapeutic target for breast cancer.
PMID: 32963598 [PubMed - as supplied by publisher]
Source: Experimental and Therapeutic Medicine - Category: General Medicine Tags: Exp Ther Med Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | General Medicine | Genetics | Stem Cell Therapy | Stem Cells | Study